Newsroom
Category
July 14, 2022
Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of the MOMENTUM phase 3 randomized […]
July 12, 2022
Black women die of breast cancer at rates nearly 40% higher than white women, despite having lower instances of the disease, because of racial disparities in care, according to a New England Journal of Medicine article by a UT Health San Antonio surgical oncologist and two American Cancer Society scientists. The authors, led by Ismail […]
June 27, 2022
Dr. Amelie G. Ramirez, Population Health Sciences and Institute for Health Promotion Research, is listed as a grant winner in this article. Read More
June 24, 2022
Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor, has designated The University of Texas Health Science Center at San Antonio (UT Health San Antonio) as a Pheo Para Center of Excellence. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multidisciplinary care and […]
June 21, 2022
Dr. Ismail Jatoi, Mays Cancer Center, was interviewed for this story about his recently published study. Read More
June 17, 2022
In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.
